Community Action Publishing
A new phase of Open Access designed for selectivity.
- Cost to publish is assessed based on publication needs of both corresponding and contributing authors so the cost of publishing is distributed more equitably among representative institutions
- Institutions commit to a yearly flat fee, ensuring their researchers receive access to unlimited publishing opportunities in PLOS Biology and PLOS Medicine.
- Revenue exceeding the community targets goes back to members at renewal. Our margins are capped so the more institutions who join in this effort, the lower costs become for all.
Why we need YOU
Our collective action model is the first sustainable Open Access solution that protects authors from the rising costs of selectivity. Eventually, we hope to eliminate APCs for all authors. But we need your help for it to work.
In order to provide truly equal access, we need a majority of our partner institutions to participate to hit each community’s revenue target. Revenue beyond that target will be redistributed to community members the following year.
We want to make Open Access more accessible.
Since highly selective publishing is resource intensive, APCs associated with making that content open can be very high. Because we believe every researcher should have the freedom to publish in the Open Access venue of their choice, we’ve used a cross-subsidy model to keep APCs of our most selective journals lower than their true publishing cost. Community Action Publishing will more equitably remove barriers to publication by covering journal costs, capping margins, and redistributing revenues beyond the target back to community members.
PLOS Biology has always put research and researchers first in order to push boundaries in the life sciences. Research questions and scientific rigor, not just positive results, define how we select significant research. And we provide authors diverse open science options to tell the fully story of their research.
Authors who publish in PLOS Medicine ensure their research–which is of global importance–is not part of a closed system. Our journal reflects the diversity of medicine and makes significant advances equally available to doctors, teachers, policymakers, and patients with the highest levels of transparency.
|Direct + Indirect Costs||$1,997,015|
|10% Operating Margin||$199,700|
|Community Cost Recovery Target||$2,196,715|
|Direct + Indirect Costs||$1,422,930|
|10% Operating Margin||$142,295|
|Community Cost Recovery Target||$1,565,225|
As of January 1 authors will only incur fees if their institutions are not members of the journal’s collective action community. For work submitted in 2021 these non-member fees are $4000 for PLOS Medicine articles and $3350/ $2350/ $4000 respectively for PLOS Biology’s Discovery Reports, Update Articles, and all other primary research articles. See our FAQs page for more details